Report overview
Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system?s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
This report contains market size and forecasts of Veterinary Biological Vaccines in global, including the following market information:
Global Veterinary Biological Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Veterinary Biological Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Veterinary Biological Vaccines companies in 2021 (%)
The global Veterinary Biological Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Live Attenuated Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veterinary Biological Vaccines include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Yebio, DHN and WINSUN, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Biological Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Biological Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biological Vaccines Market Segment Percentages, by Type, 2021 (%)
Live Attenuated Vaccines
Inactivated Vaccines
Others
Global Veterinary Biological Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biological Vaccines Market Segment Percentages, by Application, 2021 (%)
Livestock
Swine
Chicken
Others
Global Veterinary Biological Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Veterinary Biological Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Veterinary Biological Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Veterinary Biological Vaccines revenues share in global market, 2021 (%)
Key companies Veterinary Biological Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Veterinary Biological Vaccines sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products
